Abundance Wealth Counselors’s GSK GSK Stock Holding History

Abundance Wealth Counselors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.83M	Sell	33,131 -1,536	-4%	-$83.2K	0.26%	56
2025 Q4	$1.7M	Buy	34,667 +111	+0.3%	+$5.18K	0.29%	57
2025 Q3	$1.49M	Buy	34,556 +928	+3%	+$36.2K	0.26%	68
2025 Q2	$1.29M	Buy	33,628 +8,226	+32%	+$314K	0.24%	69
2025 Q1	$984K	Buy	25,402 +4,391	+21%	+$161K	0.21%	88
2024 Q4	$711K	Sell	21,011 -1,404	-6%	-$50.5K	0.15%	101
2024 Q3	$916K	Buy	22,415 +731	+3%	+$29.9K	0.19%	89
2024 Q2	$835K	Buy	21,684 +1,868	+9%	+$78.6K	0.38%	50
2024 Q1	$850K	Buy	19,816 +1,343	+7%	+$55.4K	0.2%	81
2023 Q4	$685K	Buy	18,473 +1,957	+12%	+$70.3K	0.18%	89
2023 Q3	$599K	Buy	16,516 +1,273	+8%	+$45.2K	0.17%	88
2023 Q2	$543K	Sell	15,243 -11	-0.1%	-$395	0.28%	41
2023 Q1	$543K	Buy	+15,254	New	+$534K	0.14%	99
2021 Q2	–	Sell	-80	Closed	-$4K	–	197
2021 Q1	$4K	Buy	+80	New	+$3.63K	﹤0.01%	299

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Abundance Wealth Counselors's GSK Position: Q1 2026 in Review

Abundance Wealth Counselors reduced its GSK (GSK) stake by 4.4% in Q1 2026, selling an estimated $83.2K and leaving 33,131 shares worth $1.83M. The position accounts for 0.26% of the portfolio, ranked #56.

Abundance Wealth Counselors first reported a position in GSK in Q1 2021 and has held it in 14 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Abundance Wealth Counselors held 33,131 shares of GSK worth $1.83M as of Q1 2026.
Abundance Wealth Counselors sold 1,536 GSK shares in Q1 2026, an estimated $83.2K.
GSK made up 0.26% of Abundance Wealth Counselors's portfolio in Q1 2026, its #56 holding.
Abundance Wealth Counselors first reported a position in GSK in Q1 2021 and has held it in 14 quarters since.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Abundance Wealth Counselors's 13F filing for Q1 2026, filed 23 Apr 2026.